PLEASE NOTE: You will be required to keep your camera on at all times in order for your attendance to count.
VIRTUAL
Oct 9-18, 2023
Weekdays
12:00pm – 1:00pm
Monday, Oct 9
Tuesday, Oct 10
Wednesday, Oct 11
Thursday, Oct 12
Friday, Oct 13
Monday, Oct 16
Tuesday, Oct 17
Wednesday, Oct 18
VIRTUAL
Oct 30 – Nov 22, 2023
Mondays & Wednesdays
5:00pm – 6:00pm
Monday, Oct 30
Wednesday, Nov 1
Monday, Nov 6
Wednesday, Nov 8
Monday, Nov 13
Wednesday, Nov 15
Monday, Nov 20
Wednesday, Nov 22
* NOW VIRTUAL *
Saturday, Dec 2, 2023
8:00am – 4:30pm
What the Course is About
This course will satisfy the one-time eight-hour training on treating and managing patients with opioid or other substance use disorders required by the DEA for registered physicians and practitioners as set forth in the Medication Access and Training Expansion Act. Attendees will receive up to eight hours of qualifying CME as outlined in the accreditation statements.
Attendees must participate in at least one lecture from each of the topics listed below in order to satisfy the eight-hour DEA training requirement. Attendees will receive only one hour of CME per topic.
Topics Include:
* Opioid Epidemic and Oklahoma Response
* Neurobiology of Addiction
* CDC Guidelines
* Proper Prescribing
* Opioid Treatment
* Pain Management
* Special Populations
Speakers
Jason W. Beaman, DO, MS, MPH, FAPA
Jason Beaman, DO is the Chair of the Psychiatry and Behavioral Sciences Department at Oklahoma State University Center for Health Sciences. Dr. Beaman completed his medical degree at Oklahoma State University College of Osteopathic Medicine. He then completed two simultaneous residencies in Psychiatry and Family Medicine, a fellowship in Forensic Psychiatry at Case Western Reserve University, a master’s in Pharmacology with an emphasis in Forensics at the University of Florida, and a Master’s in Public Health from Johns Hopkins University. Dr. Beaman is board certified in Psychiatry, Family Medicine, Forensic Psychiatry, and Addiction Medicine.
C. Scott Anthony, DO
C. Scott Anthony, DO received his medical training at the Oklahoma State University College of Osteopathic Medicine in 1990. He then completed a residency in anesthesiology, as well as a pain management fellowship, at Washington University/Barnes Hospital in St. Louis, Missouri. He received board certification in both anesthesiology and pain medicine through the American Board of Anesthesiology.
Lowell J. Robertson, MD
Lowell Robertson, MD is a physician in Internal Medicine and Addiction Medicine at Grand Addiction Recovery Center. Dr. Robertson completed his medical degree at the University of Oklahoma and a fellowship in Addiction Medicine at OSU Medical Center. He is Eastern Oklahoma Director of the Oklahoma Health Professionals program.
Agendas
PLEASE NOTE: You will be required to keep your camera on at all times in order for your attendance to count.
Virtual Agenda
October 9-18, 2023
Virtual Agenda
October 30 – November 22, 2023
| 10/9 at 12pm | Neurobiology of Addiction Lowell Robertson, MD Click Here for Slides |
| 10/10 at 12pm | Opioid Epidemic Jason Beaman, DO Click Here for Slides |
| 10/11 at 12pm | CDC Guidelines Jason Beaman, DO Click Here for Slides |
| 10/12 at 12pm | Opioid Treatment (part 1) Jason Beaman, DO Click Here for Slides - parts 1 & 2 |
| 10/13 at 12pm | Opioid Treatment (part 2) Jason Beaman, DO Click Here for Slides - parts 1 & 2 |
| 10/16 at 12pm | Proper Prescribing (with emphasis on OK law) Jason Beaman, DO Click Here for Slides |
| 10/17 at 12pm | Pain Management C. Scott Anthony, DO Click Here for Slides |
| 10/18 at 12pm | Special Populations Jason Beaman, DO Click Here for Slides |
| 10/30 at 5pm | Opioid Epidemic Jason Beaman, DO Click Here for Slides |
| 11/1 at 5pm | CDC Guidelines Jason Beaman, DO Click Here for Slides |
| 11/6 at 5pm | Neurobiology of Addiction Lowell Robertson, MD Click Here for Slides |
| 11/8 at 5pm | Proper Prescribing (with emphasis on OK law) Jason Beaman, DO Click Here for Slides |
| 11/13 at 5pm | Opioid Treatment (part 1) Jason Beaman, DO Click Here for Slides - parts 1 & 2 |
| 11/15 at 5pm | Opioid Treatment (part 2) Jason Beaman, DO Click Here for Slides - parts 1 & 2 |
| 11/20 at 5pm | Pain Management C. Scott Anthony, DO Click Here for Slides |
| 11/22 at 5pm | Special Populations Jason Beaman, DO Click Here for Slides |
Virtual Agenda
Saturday, December 2, 2023
| 8:00 - 9:00am | Opioid Epidemic Jason Beaman, DO Click Here for Slides |
| 9:00 - 10:00m | Neurobiology of Addiction Lowell Robertson, MD or Jason Beaman, DO Click Here for Slides |
| 10:00 - 11:00am | CDC Guidelines Jason Beaman, DO Click Here for Slides |
| 11:00am - 12:00pm | Proper Prescribing (with emphasis on OK law) Jason Beaman, DO Click Here for Slides |
| 12:00 - 12:30pm | LUNCH BREAK |
| 12:30 - 1:30pm | Opioid Treatment (part 1) Jason Beaman, DO Click Here for Slides - parts 1 & 2 |
| 1:30 - 2:30pm | Opioid Treatment (part 2) Jason Beaman, DO Click Here for Slides - parts 1 & 2 |
| 2:30 - 3:30pm | Pain Management C. Scott Anthony, DO Click Here for Slides |
| 3:30 - 4:30pm | Special Populations Jason Beaman, DO Click Here for Slides |
Attendance Requirements
This course will satisfy the one-time eight-hour training on treating and managing patients with opioid or other substance use disorders required by the DEA for registered physicians and practitioners as set forth in the Medication Access and Training Expansion (MATE) Act. Attendees will receive up to eight (8) hours of qualifying CME as outlined in the accreditation statements.
Attendance will be strictly enforced. Attendees must participate in at least one lecture from each of the topics listed below in order to satisfy the eight-hour DEA training requirement and receive their completion certificate. If you are unable to attend any lecture, please let us know so that we may try to accommodate your attendance at a future presentation. Attendees will receive only one hour of CME per topic.
Please note, there will be very specific attendance requirements for in-person and virtual attendees…
IN-PERSON ATTENDEES – Will be required to sign-in upon arrival and sign-out before departure, this includes lunchtime.
VIRTUAL ATTENDEES – Must have their cameras on and be visible during the entire lecture for your attendance to qualify.
Resources
DEA Notice to License Holders – A letter from the DEA to registered practitioners with information on the training requirements
DEA FAQ’s from the Clinical Options website
Article from Policy & Medicine: MATE Act Becomes Law: DEA Healthcare Provider License Holders Required to Complete 8 Hours of Education on Opioid Treatment
Article from Policy & Medicine: DEA Publishes Requirements for MATE Act One Time Requirement for Eight Hours of Substance Abuse Disorder Training
Target Audience
This program will provide a broad overview of addiction medicine. It is designed to satisfy the one-time eight-hour training on treating and managing patients with opioid or other substance use disorders required by the DEA for registered physicians and practitioners as set forth in the Medication Access and Training Expansion Act.
Program Objectives
This program will provide a broad overview of addiction medicine. It is designed to satisfy the one-time eight-hour training on treating and managing patients with opioid or other substance use disorders required by the DEA for registered physicians and practitioners as set forth in the Medication Access and Training Expansion Act.
Upon completion of this program, attendees will be able to:
- Classify addiction as an illness and identify current treatment trends to counteract the biologic basis of addiction.
- Examine the history of opioid epidemics in the US and discuss the severity of the current epidemic with application facts and statistics. Identify current treatment efforts to combat the opioid epidemic.
- Comprehend the genesis and transformation of the 2016 CDC Guidelines to establish the current guidelines.
- Identify the different opioid conditions and the various methods to treat each, including emerging trends.
- Understand the appropriate use of controlled substances and when and how to properly prescribe them for treatment.
- Classify the different types of pain, recognize the consequences, and discuss the various approaches to treatment.
- Discuss the diagnoses and treatment of co-occurring substance use and other psychiatric disorders. Compare strategies for treating acute, perioperative, and chronic pain for patients taking buprenorphine. Evaluate appropriate treatment options for opioid use disorder in pregnant patients, adolescents, the elderly, and those with HIV. Weigh the effects of liver and kidney impairments when treating patients with OUD.
Accreditation Statements
The Osteopathic Founders Foundation is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The Osteopathic Founders Foundation designates these activities for a maximum of eight (8) AOA category 1-A credits for all osteopathic physicians who complete and return both an attestation and evaluation for all sessions attended. Credit will be commensurate with the extent of the physician’s participation in this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Oklahoma State Medical Association (OSMA) through the joint providership of Saint Francis Health System and the Osteopathic Founders Foundation.
Saint Francis Health System is accredited by the Oklahoma State Medical Association to sponsor continuing medical education for physicians.
Saint Francis Health System designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Approval will be requested from the Oklahoma State Board of Osteopathic Examiners and the Oklahoma Board of Medical Licensure and Supervision for the Opioid Epidemic and Oklahoma Response lecture provided by Jason Beaman, DO, MS, MPH, FAPA to meet their annual licensure renewal requirement for one (1) hour of education in pain management or one (1) hour of education in opioid use or addiction.
PLEASE NOTE: You will be required to keep your camera on at all times in order for your attendance to count.
Please Note: In the event of a registration cancellation, refunds will be subject to a 3.1% administration fee, which will be deducted from the amount of the refund.
